Alan H. Gradman

4.6k total citations
90 papers, 3.4k citations indexed

About

Alan H. Gradman is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Alan H. Gradman has authored 90 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Cardiology and Cardiovascular Medicine, 31 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Surgery. Recurrent topics in Alan H. Gradman's work include Blood Pressure and Hypertension Studies (47 papers), Hormonal Regulation and Hypertension (31 papers) and Renin-Angiotensin System Studies (24 papers). Alan H. Gradman is often cited by papers focused on Blood Pressure and Hypertension Studies (47 papers), Hormonal Regulation and Hypertension (31 papers) and Renin-Angiotensin System Studies (24 papers). Alan H. Gradman collaborates with scholars based in United States, Switzerland and Germany. Alan H. Gradman's co-authors include Jan Basile, George L. Bakris, Barry L. Carter, Juerg Nussberger, Roland E. Schmieder, R. Lins, Prakash Deedwania, Martin P. Bedigian, YannTong Chiang and Bertram Pitt and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Alan H. Gradman

90 papers receiving 3.2k citations

Peers

Alan H. Gradman
Jan Basile United States
Ettore Ambrosioni Italy
Serap Erdine Türkiye
Giuliano Tocci Italy
Mary Ann Lukas United States
Steven G. Chrysant United States
P S Sever United Kingdom
Kimberley A. Eberlein United States
Joel M. Neutel United States
Steven M. Smith United States
Jan Basile United States
Alan H. Gradman
Citations per year, relative to Alan H. Gradman Alan H. Gradman (= 1×) peers Jan Basile

Countries citing papers authored by Alan H. Gradman

Since Specialization
Citations

This map shows the geographic impact of Alan H. Gradman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan H. Gradman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan H. Gradman more than expected).

Fields of papers citing papers by Alan H. Gradman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan H. Gradman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan H. Gradman. The network helps show where Alan H. Gradman may publish in the future.

Co-authorship network of co-authors of Alan H. Gradman

This figure shows the co-authorship network connecting the top 25 collaborators of Alan H. Gradman. A scholar is included among the top collaborators of Alan H. Gradman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan H. Gradman. Alan H. Gradman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Basile, Jan, Jiang He, Shawna D. Nesbitt, & Alan H. Gradman. (2018). Treating Special Populations with Hypertension: Is a Two-Drug or Fixed-Dose Combination Therapy Appropriate Initial Treatment in Hypertension?. 1 indexed citations
2.
Egan, Brent M., et al.. (2017). CARDIOVASCULAR OUTCOMES WITH NEBIVOLOL, ATENOLOL AND METOPROLOL IN PATIENTS WITH HYPERTENSION: A LARGE, RETROSPECTIVE, PROPENSITY SCORE-MATCHED COHORT STUDY. Journal of the American College of Cardiology. 69(11). 1691–1691. 1 indexed citations
3.
4.
Gradman, Alan H., et al.. (2008). Renin Inhibition in Hypertension. Journal of the American College of Cardiology. 51(5). 519–528. 93 indexed citations
5.
Gradman, Alan H., et al.. (2008). Vaccination: A novel strategy for inhibiting the renin-angiotensin-aldosterone system. Current Hypertension Reports. 10(6). 473–479. 4 indexed citations
6.
Arora, Sandeep, Kofi Clarke, Venkatraman Srinivasan, & Alan H. Gradman. (2007). Effect of nesiritide on renal function in patients admitted for decompensated heart failure. QJM. 100(11). 699–706. 13 indexed citations
7.
Gradman, Alan H., et al.. (2006). Hypertension in the elderly. Cardiology in Review. 23(9). 24–34. 2 indexed citations
8.
Gradman, Alan H., et al.. (2006). From Left Ventricular Hypertrophy to Congestive Heart Failure: Management of Hypertensive Heart Disease. Progress in Cardiovascular Diseases. 48(5). 326–341. 221 indexed citations
9.
Srinivasan, Venkatraman, et al.. (2004). Reducing Radiocontrast Use in the Cardiac Catheterization Laboratory—A Behavioral Modification Approach. Quality Management in Health Care. 13(3). 188–192. 4 indexed citations
10.
11.
Gradman, Alan H., et al.. (2002). Evolving strategies for the use of combination therapy in hypertension. Current Hypertension Reports. 4(5). 343–349. 37 indexed citations
12.
Gradman, Alan H., et al.. (2000). Underutilization and clinical benefits of angiotensin-converting enzyme inhibitors in patients with asymptomatic left ventricular dysfunction. The American Journal of Cardiology. 86(6). 644–648. 15 indexed citations
13.
Gradman, Alan H., et al.. (1999). Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension. Clinical Therapeutics. 21(3). 442–453. 31 indexed citations
14.
Gradman, Alan H., Neal R. Cutler, Pamela J. Davis, et al.. (1998). Long-term efficacy, tolerability, and safety of the combination of enalapril and felodipine ER in the treatment of hypertension. Clinical Therapeutics. 20(3). 527–538. 5 indexed citations
15.
Gradman, Alan H., et al.. (1997). Combined Enalapril and Felodipine Extended Release (ER) for Systemic Hypertension. The American Journal of Cardiology. 79(4). 431–435. 82 indexed citations
16.
Mehta, Jawahar L., Larry M. Lopez, N. D. Vlachakis, et al.. (1993). Double-blind evaluation of the dose-response relationship of amlodipine in essential hypertension. American Heart Journal. 125(6). 1704–1710. 23 indexed citations
17.
Colfer, Harry T., Hillel S. Ribner, Alan H. Gradman, et al.. (1992). Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. The American Journal of Cardiology. 70(3). 354–358. 20 indexed citations
18.
Townsend, Raymond R., Donald J. DiPette, Robert P. Goodman, et al.. (1990). Combined α/β-blockade versus β1-selective blockade in essential hypertension in black and white patients. Clinical Pharmacology & Therapeutics. 48(6). 665–675. 26 indexed citations
19.
Gradman, Alan H., Prakash Deedwania, Robert Cody, et al.. (1989). Predictors of total mortality and sudden death in mild to moderate heart failure. Journal of the American College of Cardiology. 14(3). 564–570. 329 indexed citations
20.
Gradman, Alan H.. (1979). Rapid Progression in Valvular Aortic Stenosis. CHEST Journal. 76(4). 376–377. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Basile Breakdown of academic impact, for papers by Ettore Ambrosioni Breakdown of academic impact, for papers by Serap Erdine Breakdown of academic impact, for papers by Giuliano Tocci Breakdown of academic impact, for papers by Mary Ann Lukas Breakdown of academic impact, for papers by Steven G. Chrysant Breakdown of academic impact, for papers by P S Sever Breakdown of academic impact, for papers by Kimberley A. Eberlein Breakdown of academic impact, for papers by Joel M. Neutel Breakdown of academic impact, for papers by Steven M. Smith
Rankless by CCL
2026